openPR Logo
Press release

Market Forecast for Genetic Testing by 2024 Key Vendors are Genentech, bioMérieux, 23andMe, Genomic Health, Myriad Genetics, Natera Abbott Molecular Inc, Bayer Diagnostics, Biocartis, BioHelix, Cepheid, Counsyl, HTG Molecular Diagnostics, IntegraGen, Lab

10-07-2018 08:08 PM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Genetic Testing Market

Genetic Testing Market

Innovation in genetic testing leading to enhanced efficiency, high sensitivity and safety will serve to be a high impact rendering factor. Technological advancement in scientific research as well as research instrument is increasing the importance of genetic testing. Availability of sensitive and efficient DNA sequencing technique for prenatal genetic testing allows detection of minute amount of DNA circulating in the mother’s blood during early stages of pregnancy. Adoption of such non-invasive prenatal testing (NIPT) at a very early stage of pregnancy is increasing worldwide thereby augmenting the industry growth over the forecast period.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2490

Demand for direct-to-consumer (DTC) genetic testing is growing in the last few years. DTC genetic testing allows customers to know their genetic information without involving the physicians or other healthcare professionals. DTC testing allows customers to identify genetic predisposition to diseases such as cancer, Alzheimer’s and diabetes in order to facilitate a precautionary preparation for healthcare. Aforementioned factors will further boost the market growth over the forecast period.

However, the high cost involved in genetic testing coupled with ambiguous reimbursement structure in different regions, lack of experienced professionals and lack of advanced infrastructure in developing economies will hamper the industry growth during the forecast period.

Prenatal and newborn testing segment is projected to show lucrative growth during the forthcoming years owing to the rising prevalence of genetic disorders and chromosomal anomalies. Increasing number of consanguineous marriages in developing nations result in genetic disorders and autosomal recessive diseases. Resulting upswing in cases of births with genetic abnormalities will fuel the demand for use of prenatal and newborn genetic testing to detect probabilities of birth defect.

Cancer diagnosis segment accounted for the largest market share in 2017. Cancer is the second leading cause of mortality globally. According to, The Institute for Health Metrics and Evaluation (IHME), the number of cancer deaths accounted for around 8.9 million in 2016. Around 5%-10% of all the cancers globally are caused by inheriting genetic mutation. Notable improvements can be made in the lives of cancer patients by diagnosing cancer early and avoiding delays in care resulting in greater probability of surviving, less expensive treatment and reduced morbidity. Rising prevalence of cancer worldwide will significantly accelerate the cancer diagnosis segment over the forecast period.

U.S. dominated the genetic testing market in 2017 and will witness robust growth during the forecast period. This is attributable to the rising prevalence of genetic diseases, highly advanced infrastructure to support genetic testing and technological advancements in the region. The regulatory support for direct to consumer (DTC) genetic testing coupled with increasing insurance coverage and reduction in the cost of genetic tests is projected to fuel the demand for genetic testing in the U.S.

Genetic testing market in Japan accounted for the largest market share in Asia-Pacific region and is expected to show significant growth over the coming years. This is attributable to factors such as growing advancements in the technology, availability of new tests, rapidly rising patient pool and increasing government investment in R&D. Further, India and China are expected to grow at a faster CAGR due to the increasing disposable income, rising affordability and growing investments in healthcare infrastructure. Aforementioned factors will further fuel the regional growth throughout the forecast period.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2490

Some of the notable industry players operating in global genetic testing market are 23andMe, Abbott Molecular, Bayer Diagnostics, Biocartis, BioHelix, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, Genomic Health, HTG Molecular Diagnostics, IntegraGen, LabCorp Diagnostics, Luminex, MolecularMD, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, Roche Diagnostics, Sequenom and Siemens. Industry players are focusing on strategic expansion through acquisitions, mergers and collaborations help the players to strengthen and enhance the product portfolio. For instance, in December 2017, Roche acquired Ariosa Diagnostics, a molecular diagnostic testing services provider, to enter the non-invasive prenatal test (NIPT) and cell-free DNA testing services market.

About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: http://exsoft.org/category/health/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Market Forecast for Genetic Testing by 2024 Key Vendors are Genentech, bioMérieux, 23andMe, Genomic Health, Myriad Genetics, Natera Abbott Molecular Inc, Bayer Diagnostics, Biocartis, BioHelix, Cepheid, Counsyl, HTG Molecular Diagnostics, IntegraGen, Lab here

News-ID: 1285377 • Views: 3385

More Releases from Global Market Insights, Inc.

Glutathione market trends will be driven by rising beauty products demand
The rising beauty products demand influence global glutathione market size. Reports estimate that Germany oxidized glutathione market share is expected to surpass USD 7.5 million by 2025. The product is chosen as GSSG and is extensively used in the production of lotions, soaps, and creams due to its skin whitening effects. From the last few years, manufacturers have swiftly increased their production capacities as these supplements are found to be
Aroma chemicals market size is slated to grow robustly by 2026, boosted by the f …
In the latest research report compiled by Global Market Insights, Inc., aroma chemicals market size to reach USD 7.5 billion by 2026. Aroma chemicals have been become a highly sought-after compound in the production of flavorant that is used in the food and beverage industry to boost and enhance the appeal of the products. As such, demand for aroma chemicals in essential oils, fragrance oils, food, wine and spices has become
Top 3 trends accentuating Plastomer Market size until 2025
The plastomer market is expected to grow exceptionally by 2025 owing to increasing efforts on research and development by the key auto automobile players in the industry. Plastomer has found considerable application across diverse industries in products like adhesives, compounding foams, and in food and non-food packaging. The material is used to make automotive interiors like seat belts that are made of nylon or polyester, wires and cables. Driven by
Oilfield surfactants market to see 4% CAGR over 2020-2026 | Key players are Saso …
Oilfield surfactants demonstrate significant application potential in oil recovery processes, aiding in the displacement of oil near the well. This displacement can aid the production of low mobility foam, and lower interfacial tension by improving the mobility of the oil. Based on product type, the global oilfield surfactants market is broadly categorized into cationic, non-ionic, silicone, anionic, and amphoteric, which are chosen for different oil exploration activities depending on the

All 5 Releases


More Releases for Genetic

Preimplantation Genetic Testing Market is Blooming Worldwide
HTF MI recently introduced Global Preimplantation Genetic Testing Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. At present, the market is developing its presence and some of the key players from the complete study are F. Hoffmann-La Roche, Abbott Laboratories, Thermo Fisher Scientific, Natera, Illumina & Perkin Elmer etc. The market Study is segmented by key regions which
Genetic Analysis ASProduct Pipeline Analysis, 2017 Update
"The Report Genetic Analysis ASProduct Pipeline Analysis, 2017 Update provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Genetic Analysis ASProduct Market Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of
Preimplantation Genetic Diagnosis: Scope & Revenue Outlook
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the
India Genetic Testing Market Analysis
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest causes of mortality in neonates in cities. The ability to identify these non-communicable diseases at an early stage lies within the genetic screening segment. Genetic screening, however, is still in its infancy and there are many challenges that need to be overcome in order to
Genetic Testing Services Market Analysis – 2023
Genetic testing is one of the most rapidly growing segments in molecular diagnostics industry that helps in delivering customized health services and is also called as personalized medicine. The genetic testing services include genetic testing, results interpretation, information analysis, education and counseling. Growing know-how about genetic testing, technological advances in genetic sequencing, rising incidences of genetic diseases especially cancer is the major factors propelling the genetic testing services market. Currently
Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder
The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region. However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that